世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000029527

次世代シーケンシング:新規臨床応用と世界市場

BCC Research

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

発刊日 2021/06

言語英語

体裁PDF/417ページ

ライセンス/価格417ページ

0000029527

Single
2-5Users
Site License
Enterprise License

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

臨床次世代シーケンシング(NGS)の世界市場は、2020年の59億ドルから2025年までに229億ドルに拡大し、2020年から2025年までのCAGRは31.4%と予想されます。

レポートの内容

  • 29のデータ表に73の表を追加
  • 次世代シーケンシング(NGS)を用いた診断および関連技術の新たな臨床応用の世界市場の最新情報
  • 2019年から2020年までのデータ、および2025年までのCAGR予測による世界市場の動向分析
  • 臨床NGS製品の事業機会、臨床応用、業界構造、規制シナリオ、および業界内におけるNGSベースの診断と技術の浸透度について
  • 世界のNGS診断市場の現在の市場規模と売上予測、それに呼応する適応疾患別、検査の複雑さ別、検査の目的別、用途別、地域別市場シェア分析
  • 業界の主要なNGSワークフロー部分(シーケンス機器、シーケンス前のターゲットの準備とキャプチャ、シーケンス後のデータ分析など)の評価、およびNGSが2025年までに大きな市場シェアを獲得する主な臨床指標
  • 主なシーケンシング技術の評価と臨床試験における遺伝的変異の重要性の説明、NGSの臨床応用に影響を与えるいくつかの重要な研究構想
  • 2019年1月から2021年4月までの臨床NGS業界における主要な買収と戦略的提携の概要(主要な提携動向を含む)
  • リキッドバイオプシー業界における米国特許の特許レビューと重要な割り当て
  • Agilent Technologies Inc.、Becton, Dickinson and Co. (BD)、Koninklijke Philips N.V.、Merck KGaA、Novogene Co. Ltd.、Oxford Nanopore Technologies Ltd.、Qiagen NV、 Roche Holding AG、Thermo Fisher Scientific Inc.など、主要プレイヤーの企業概要

レポート詳細

目次

Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter- 2: Summary and Highlights
Table Summary : Global Market for Clinical Next-Generation Sequencing, by Disease Class, Through 2025
Figure Summary : Global Market for Clinical Next-Generation Sequencing, by Disease Class, 2019-2025

Chapter- 3: Overview
Introduction
Liquid and Tissue Biopsy
Clinical NGS Testing Market
Growth Drivers of Clinical NGS
Key Trends
Industry

Chapter- 4: Technology Background
Importance of DNA
Genetic Variation and Analysis
Genetic Analysis Technologies
Sequencing in Clinical Applications
Sequencing Technologies
Informatics Technologies
Base Calling
Mapping to a Reference Sequence
Variant Analysis
Artificial Intelligence Technologies
Clinical Sequencing Technology Challenges

Chapter- 5: Clinical NGS Initiatives
R&D Initiatives and Programs
Single-Cell Research
Population Sequencing Projects
Table 26 : Clinical NGS Research and Development Initiatives and Programs

Chapter- 6: Clinical NGS Applications
Introduction
Cancer Applications
Mendelian Disorders Applications
Reproductive Health Applications
Microbiology and Infectious Disease Applications
Complex Disorders Applications

Chapter- 7: Clinical NGS Industry
Sequencing Instrument Industry
Third-Generation Sequencing Industry
Sequencing Informatics Industry
Target Enrichment and Amplification Industry
CTC Capture and Detection Industry
Liquid Biopsy Assay Industry
Liquid Biopsy Cancer Screening/Early Detection Industry
Health-Focused DTC Genetic Testing Industry: Two Market Models
DTC Clinical Health Genetic Testing Industry
Noninvasive Prenatal Testing (NIPT) Industry
Table 38 : Key Segments and Trends in the Clinical NGS Industry

Chapter- 8: Acquisitions and Strategic Alliances
Acquisitions
Strategic Alliances

Chapter- 9: Clinical NGS Markets
Market Dynamics
Clinical NGS Market by Disease Category
Geographical Markets

Chapter- 10: Patent Review
Patents on Circulating Tumor Cells
Patents on Exosomes
Patents on Cell-Free DNA
Patents Related to Biomarkers
Patent Considerations for the Use of Artificial Intelligence in Cancer Diagnostics
Liquid Biopsy Patent Litigation

Chapter- 11: Company Profiles
ACCURAGEN INC.
ADAPTIVE BIOTECHNOLOGIES INC.
AGILENT TECHNOLOGIES INC.
ALCEDIAG
AMBRY GENETICS
AMOY DIAGNOSTICS CO. LTD.
ANGLE PLC
APOCELL INC.
APOSTLE INC.
ARCEDI BIOTECH APS
ARCHER DX
ARMONICA TECHNOLOGIES INC.
ARUP LABORATORIES
ASURAGEN INC.
AVIVA BIOMED INC.
AVIVA BIOSCIENCES
BARD1 LIFE SCIENCES LTD.
BASE GENOMICS
BAYLOR GENETICS
BECTON, DICKINSON AND CO.
BERRY GENOMICS CO. LTD.
BGI SHENZHEN
BIOCAPTIVA LTD.
BIOCEPT INC.
BIODESIX INC.
BIOFLUIDICA INC.
BIOLIDICS LTD.
BIOLOGICAL DYNAMICS INC.
BIONANO GENOMICS
BIO-TECHNE CORP.
BITBIOME, INC.
BLUESTAR GENOMICS INC.
BURNING ROCK BIOTECH LTD.
C2I GENOMICS
CAMBRIDGE EPIGENETIX
CANCER GENETICS INC.
CANEXIA HEALTH
CAPIO BIOSCIENCES
CAPTIS DIAGNOSTICS INC.
CAREDX INC.
CARIS LIFE SCIENCE
CEGAT GMBH
CELLMAX LIFE
CELL MICROSYSTEMS INC.
CELSEE DIAGNOSTICS
CENTRILLION GENOMICS TECHNOLOGIES
CHRONIX BIOMEDICAL
CIRCULOGENE THERANOSTICS
CLARET BIOSCIENCE
CLINICAL GENOMICS TECHNOLOGIES
CODIAK BIOSCIENCES
COGENICA
CRADLE GENOMICS
CYCLOMICS
CYGNUS BIOSCIENCES CO. LTD.
CYTOTRACK APS
DANAHER CORP.
DANTE LABS
DATAR CANCER GENETICS LTD.
DELFI DIAGNOSTICS
DIACARTA INC.
DIAGNOLOGIX LLC
DIAGNOMICS
DIAMIR BIO
DNALYTICS
DNANEXUS INC.
DOVETAIL GENOMICS LLC
EARLYDX INC.
EONE-DIAGNOMICS GENOME CENTER
ENCRYPGEN
EPIC SCIENCES INC.
EPIGENOMICS AG
EUROFINS SCIENTIFIC
EXACT SCIENCES CORP.
EXOSOME SCIENCES INC.
EXOSOMICS SPA
EXOPERT
EZLIFE BIO INC.
FABRIC GENOMICS
FLUXION BIOSCIENCES INC.
FREENOME INC.
FULGENT GENETICS INC.
FULL GENOMES CORP. INC.
GENAPSYS INC.
GENE BY GENE LTD.
GENEDX INC.
GENETRON HEALTH TECHNOLOGIES
GENESEQ BIOSCIENCES PTY LTD.
GENEXOSOME TECHNOLOGIES INC.
GENOMICTREE
GENOMONCOLOGY
GENOSABER
GENOSITY
GRAIL INC.
GUARDANT HEALTH INC.
HELIO HEALTH
HELIX OPCO LLC
HITGEN
HTG MOLECULAR DIAGNOSTICS INC.
ID SOLUTIONS
ILLUMINA INC.
INCELLDX INC.
INEX INNOVATE PTE. LTD.
INIVATA LTD.
INSITOME INC.
INTERPACE BIOSCIENCES INC.
INVITAE INC.
INVIVOSCRIBE INC.
JABREHOO MEDTECH CO., LTD.
JBS SCIENCE INC.
JUMPCODE GENOMICS INC.
KONINKLIJKE PHILIPS N.V.
LABORATORY CORP. OF AMERICA INC.
LABGENOMICS CO., LTD.
LABRINTH BIOTECH INC.
LARIAT BIOSCIENCES INC.
LIQUID BIOPSY LABS
LUCENCE DIAGNOSTICS PTE. LTD.
LUNGLIFE AI INC.
MACROGEN INC.
MAPMYGENOME
MDXHEALTH INC.
MEDGENOME INC.
MENARINI SILICON BIOSYSTEMS SPA
MERCK KGAA
MICAREO RARE CELL DIAGNOSTICS
MICRONOMA
MIR SCIENTIFIC
MUTANTDX
MYRIAD GENETICS INC.
NAMOCELL INC.
NANOSTRING TECHNOLOGIES INC.
NANOVIEW BIOSCIENCES INC.
NATERA INC.
NEBULA GENOMICS
NEOGENOMICS LABORATORIES
NEO NEW ONCOLOGY GMBH
NEW ENGLAND BIOLABS
NEW HORIZON HEALTH LTD.
NIPD GENETICS
NOVIGENIX SA
NOVOGENE CO. LTD.
NRICHDX INC.
NUPROBE INC.
NX PRENATAL INC.
ONCIMMUNE HOLDINGS PLC
ONCOCYTE CORP.
ONCODNA S.A.
OPKO HEALTH
ORCHID HEALTH INC.
OXFORD NANOPORE TECHNOLOGIES LTD.
PACIFIC BIOSCIENCES OF CALIFORNIA INC.
PANGAEA ONCOLOGY
PERSONAL GENOME DIAGNOSTICS INC.
PERSONALIS INC.
PFDENA INC.
PHASE SCIENTIFIC
PHOSPHORUS INC.
PIERIANDX
PWNHEALTH
PREDICINE INC.
PRENETICS GROUP
QCDX LLC
QIAGEN NV
QUANTAPORE INC.
QUANTGENE INC.
QUANTUM BIOSYSTEMS INC.
QUANTUMDX
QUEST DIAGNOSTICS INC.
RARECELLS SAS
RAVGEN
REAL TIME GENOMICS INC.
RESOLUTION BIOSCIENCE INC.
ROCHE HOLDING AG
SAGA DIAGNOSTICS AB
SANO GENETICS
SANOMICS LTD.
SCREENCELL
SEEKIN
SERACARE LIFE SCIENCES INC.
SEQUENCING.COM
SEVEN BRIDGES GENOMICS INC.
SINGLE TECHNOLOGIES
SINGLERA GENOMICS INC.
SMARTCACTCH
STAGE ZERO LIFE SCIENCES
STRAND LIFE SCIENCES PVT. LTD.
STRATA ONCOLOGY
STRATOS GENOMICS INC.
SYAPSE
SYSMEX INOSTICS GMBH
TAILAI BIOSCIENCES CO., LTD.
TAKARA BIO INC.
TELEXOS GMBH
THERMO FISHER SCIENTIFIC INC.
TWINSTRAND BIOSCIENCES
TWIST BIOSCIENCE
UBIQUITY GENOMICS INC.
UNIVERSAL DIAGNOSTICS SL
VELA DIAGNOSTICS
VERACYTE
VOLITIONRX
VORTEX BIOSCIENCES
XING TECHNOLOGIES LLC
YOURGENE HEALTH PLC
YIKON GENOMICS CO. LTD.

この商品のレポートナンバー

0000029527

TOP